How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19
Learn More
Share
Latest News
Featured Stories
March 30, 2020
More from Johnson & Johnson
The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.
The company received its highest-ever ranking on the list this year—which honors global supply chain excellence—in part for its nimble response to the COVID-19 pandemic.
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
